SCHEMBL6406035

SCHEMBL6406035

c1ccc(Oc2ccc(-c3ccc(-c4ccc(Oc5ccccc5)cc4)cc3)cc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 9/20 0.75
TSHR P16473 1/20 0.75
GSTP1 P09211 1/20 0.62
NR1H2 P55055 1/20 0.62
BAX Q07812 1/20 0.62
MAOA P21397 1/20 0.62
CA1 P00915 2/20 0.54
CA2 P00918 2/20 0.54
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
SCN4A P35499 1/20 0.54
TLR8 Q9NR97 1/20 0.52
SOS1 Q07889 1/20 0.50
CA9 Q16790 1/20 0.50
PARP10 Q53GL7 1/20 0.50
NISCH Q9Y2I1 1/20 0.50
PLA2G2A P14555 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL197414 1.00 LTA4H (0.75) LTA4HTSHRGSTP1NR1H2BAX
SCHEMBL2860844 1.00 LTA4H (0.75) LTA4HTSHRGSTP1NR1H2BAX
SCHEMBL21921128 0.97 LTA4H (0.71) LTA4HTSHRGSTP1NR1H2BAX
Biphenyl SCHEMBL10838288 0.97 LTA4H (0.71) LTA4HTSHRGSTP1NR1H2BAX
SCHEMBL9190364 0.97 LTA4H (0.71) LTA4HTSHRGSTP1NR1H2BAX
SCHEMBL403667 0.97 LTA4H (0.71) LTA4HTSHRGSTP1NR1H2BAX
SCHEMBL31588897 0.94 LTA4H (0.67) LTA4HTSHRGSTP1NR1H2BAX
SCHEMBL2856821 0.94 LTA4H (0.65) LTA4HTSHRGSTP1NR1H2BAX
SCHEMBL10686173 0.94 LTA4H (0.65) LTA4HTSHRGSTP1NR1H2BAX
SCHEMBL3681820 0.94 LTA4H (0.65) LTA4HTSHRGSTP1NR1H2BAX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174498-A1 XANTHENE DERIVATIVES, MIXTURES COMPRISING SAME, MANUFACTURING METHOD AND CORRESPONDING USES ARKEMA FRANCE (FR) 2023-06-08 US disclosed
WO-2021234251-A1 XANTHENE DERIVATIVES, MIXTURES COMPRISING SAME, MANUFACTURING METHOD AND CORRESPONDING USES ARKEMA FRANCE (FR) 2021-11-25 WO disclosed
EP-3145975-B1 AMINE-DERIVATISED POLYARYLETHERKETONE COPOLYMERS KETONEX LTD (GB) 2021-03-17 EP disclosed
US-20170107323-A1 METHOD FOR MAKING PARTICULATE AMINE-FUNCTIONALIZED POLYARYLETHERKETONE POLYMERS AND COPOLYMERS THEREOF OXFORD PERFORMANCE MATERIALS, INC 2017-04-20 US disclosed
US-20050136245-A1 Intermediate transfer medium, film forming liquid for the intermediate transfer medium and image forming apparatus using intermediate transfer medium RICOH COMPANY LIMITED (JP) 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174498-A1 XANTHENE DERIVATIVES, MIXTURES COMPRISING SAME, MANUFACTURING METHOD AND CORRESPONDING USES F12, XDH, XPA LTA4H 292/4885TSHR 1516/4885GSTP1 4450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.